Mid (India) Pharmaceuticals Pvt Ltd
About Mid (India) Pharmaceuticals Pvt Ltd
Data last updated:
Mid (India) Pharmaceuticals Pvt Ltd is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 August 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U25111MP1988PTC004729.
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹69.48 Lakh. It is led by directors including Suresh Kumar Dube and Ajay Kumar Jha.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 12/B Industrial Estate Pologround, Indore, Madhya Pradesh, India – 452015.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.7 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹3.38 Lakh (net margin 31.5%) and EBITDA of ₹4.58 Lakh (EBITDA margin 42.8%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Mid (India) Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232MP1988PTC004729. The current CIN is U25111MP1988PTC004729, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U25111MP1988PTC004729 | Current |
| U24232MP1988PTC004729 | Previous |
Contact details
Mid (India) Pharmaceuticals Pvt Ltd's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 12/B Industrial Estate Pologround, Indore, Madhya Pradesh, India – 452015
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Mid (India) Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Mid (India) Pharmaceuticals Pvt Ltd
FY 2025 filings availableMid (India) Pharmaceuticals Pvt Ltd reported revenue of ₹10.7 Lakh (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 14% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 42.8% | ||||
| Net Profit Margin | 31.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mid (India) Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Mid (India) Pharmaceuticals Pvt Ltd
Mid (India) Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar Dube Also directs: Navypack Private Limited | Director | 25 Mar 2008 | 18 Years 6 Months | Current |
| Ajay Kumar Jha Also directs: Valentis Health Care Private Limited | Director | 02 Sep 2014 | 12 Years 1 Months | Current |
| Romil Shah | Director | 15 Oct 2018 | 8 Years 0 Months | Current |
Peer comparison
Mid (India) Pharmaceuticals Pvt Ltd is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medstream Pharmaceuticals (India) Private Limited | ₹10.76 Lakh (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Ak Pharmaceuticals Private Limited | ₹10.76 Lakh (FY 2025) | 22.0% | New Delhi, Delhi, India | |||
| Gabreal Pharmaceuticals Pvt Ltd | ₹10.73 Lakh (FY 2023) | -8.0% | Dombivli, Maharashtra, India | |||
| Lukem Pharmaceuticals Private Limited | ₹10.73 Lakh (FY 2025) | -30.0% | Patna, Bihar, India | |||
| Z&Z India Pharmaceuticals Private Limited | ₹10.73 Lakh (FY 2024) | 93.0% | Manimajra, Chandigarh, India | |||
| Mid (India) Pharmaceuticals Pvt Ltdthis company | ₹10.7 Lakh (FY 2025) | ₹3.38 Lakh | 31.5% | 14.0% | Indore, Madhya Pradesh, India | |
| Shinewell Pharmaceuticals Private Limited | ₹10.69 Lakh (FY 2024) | 2.0% | Nalasopara West, Maharashtra, India | |||
| Lian Pharmaceuticals Private Limited | ₹10.68 Lakh (FY 2025) | -79.0% | Bangalore, Karnataka, India | |||
| Pershona Pharmaceuticals Private Limited | ₹10.66 Lakh (FY 2022) | Durgapur, West Bengal, India | ||||
| Sorbet Pharmaceuticals Private Limited | ₹10.65 Lakh (FY 2023) | -4.0% | Katraj, Maharashtra, India | |||
| Zabetas Pharmaceuticals Private Limited | ₹10.65 Lakh (FY 2024) | 6.0% | New Delhi, Delhi, India |
To see the full peer comparison of Mid (India) Pharmaceuticals Pvt Ltd, buy the company report.
Auditor
Mid (India) Pharmaceuticals Pvt Ltd is audited by M. Khandelwal & Company for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. Khandelwal & Company | FY 2022 | 000333C |
Shareholding
The shareholding of Mid (India) Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mid (India) Pharmaceuticals Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Mid (India) Pharmaceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mid (India) Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mid (India) Pharmaceuticals Pvt Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mid (India) Pharmaceuticals Pvt Ltd has 8 board changes on record since 2008: 3 appointments and 5 cessations. The latest: Romil Shah was appointed as Director on 15 Oct 2018.
Frequently asked questions
Mid (India) Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 August 1988 (38+ years old) and is registered under CIN U25111MP1988PTC004729.
Mid (India) Pharmaceuticals has 3 current directors:
- Suresh Kumar Dube - Director
- Ajay Kumar Jha - Director
- Romil Shah - Director
The latest financial statements of Mid (India) Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Mid (India) Pharmaceuticals is U25111MP1988PTC004729. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mid (India) Pharmaceuticals was incorporated on 09 August 1988, making it 38+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Mid (India) Pharmaceuticals by revenue are Medstream Pharmaceuticals (India) Private Limited, Ak Pharmaceuticals Private Limited, Gabreal Pharmaceuticals Pvt Ltd, Lukem Pharmaceuticals Private Limited, Z&Z India Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Romil Shah was appointed as Director on 15 Oct 2018. Ajay Kumar Jha ceased to be Additional Director on 30 Sep 2014. Ajay Kumar Jha was appointed as Director on 02 Sep 2014. Mid (India) Pharmaceuticals has 8 board changes on record in total.
The registered office of Mid (India) Pharmaceuticals is at B – 12B Industrial Estate Pologround, Indore, Madhya Pradesh, India – 452015.
Mid (India) Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Mid (India) Pharmaceuticals is compliant as of 19 September 2026. The company is actively filing with the Registrar of Companies.
Mid (India) Pharmaceuticals can be reached at its registered office: B – 12B Industrial Estate Pologround, Indore, Madhya Pradesh, India – 452015.